CCEL Q4 2017 Earnings — Cryo-Cell International, Inc. Revenue & Financial Results | Market Cap Arena

CCELCryo-Cell International, Inc.

$26M

Q4 2017 Earnings

Healthcare Medical - Care Facilities

Income Statement

Revenue

$6M+10.3% YoY

Gross Profit

$5M74.7% margin

Operating Income

$1M19.2% margin

Net Income

$679,21810.5% margin

EPS (Diluted)

$0.10

QoQ Revenue Growth

-6.1%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

$2M

Stock-Based Comp.

$262,557

Balance Sheet

Total Assets

$24M

Total Liabilities

$36M

Stockholders' Equity

-$13M

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$6M	+10.3%
Gross Profit	$5M	$4M	+9.2%
Operating Income	$1M	$456,863	+172.6%
Net Income	$679,218	$809,365	-16.1%

Revenue Segments

Umbilical Cord Blood And Cord Tissue Stem Cell Service

$6M98%

Prepacyte-CB

$100,1592%

Geographic Segments

INDIA

$182,179100%